Clinical trial
Behavioral Intervention Trial to Reduce Transmission Risks and Improve HCV Treatment Access Among HCV-infected Injection Drug Users
NCT00391482 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Behavioral Intervention Trial to Reduce Transmission Risks and Improve HCV Treatment Access Among HCV-infected Injection Drug Users
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- February 28, 2005
- Enrollment
- 750
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.